Search

Tina M Morwick

from Carmel, IN
Age ~74
Get Report
Also known as:
Tina Marie Morwick
Phone and address:
5317 Ripplingbrook Way, Carmel, IN 46033
(317) 979-3167
Related to:
Joseph Kendall Morwick, 46Lisa C Hansen, 55James SwaileKimberly N, 65Kim Castello, 64
Connected to:
Aaron Mory, 41Camara Mory, 46Christa M Mory, 76Christian J Mory, 35Diane Mory, 59Everlee Mory, 49Henry A Mory, 88Jill Mory, 57Josiah Mory, 63Kimberly D Mory, 66

Tina Morwick Phones & Addresses

  • 5317 Ripplingbrook Way, Carmel, IN 46033 (317) 979-3167
  • Sevierville, TN
  • Fishers, IN
  • Brookfield, CT
  • 114 Taylor St, New Milford, CT 06776
  • Pickerington, OH
  • Indianapolis, IN

Work

Company: Independent contractor Jan 2018 Position: Medical and science writer and author and editor

Education

Degree: Doctorates, Doctor of Philosophy School / High School: The Ohio State University 1996 Specialities: Organic Chemistry

Skills

Chemistry • Lead Change • Drug Discovery • Organic Chemistry • Biotechnology • Cheminformatics • High Throughput Screening • Medicinal Chemistry • Validation • Organic Synthesis • Drug Development • Lifesciences • Life Sciences

Ranks

Certificate: Editor In the Life Sciences (Els)

Industries

Writing And Editing

Resumes

Resumes

Tina Morwick Photo 1

Medical And Science Writer And Author And Editor

View page
Location:
5317 Ripplingbrook Way, Carmel, IN 46033
Industry:
Writing And Editing
Work:
Independent Contractor
Medical and Science Writer and Author and Editor
Eli Lilly and Company Jul 1, 2013 - Dec 2017
Associate Consultant-Scientific Communications
Boehringer Ingelheim Oct 1996 - Jul 2010
Principal Scientist
Eli Lilly and Company Jan 1973 - Nov 1979
Organic Chemist
Jan 1973 - Nov 1979
Medical and Science Writer and Author and Editor
Education:
The Ohio State University 1996
Doctorates, Doctor of Philosophy, Organic Chemistry University of Indianapolis 1972
Bachelors, Bachelor of Arts, Chemistry
Skills:
Chemistry
Lead Change
Drug Discovery
Organic Chemistry
Biotechnology
Cheminformatics
High Throughput Screening
Medicinal Chemistry
Validation
Organic Synthesis
Drug Development
Lifesciences
Life Sciences
Certifications:
Editor In the Life Sciences (Els)

Publications

Us Patents

Compound Useful As Reversible Inhibitors Of Cysteine Proteases

View page
US Patent:
6420364, Jul 16, 2002
Filed:
Sep 8, 2000
Appl. No.:
09/655351
Inventors:
Michel Jose Emmanuel - Danbury CT
Leah L. Frye - Patterson NY
Eugene R. Hickey - Danbury CT
Weimin Liu - Shelton CT
Tina Marie Morwick - New Milford CT
Denice Mary Spero - West Redding CT
Sanxing Sun - Danbury CT
David S. Thomson - Ridgefield CT
Yancey David Ward - Sandy Hook CT
Erick Richard Roush Young - Danbury CT
Assignee:
Boehringer Ingelheim Pharmaceuticals, Inc. - Ridgefield CT
International Classification:
A61K 31535
US Classification:
5142315, 51425213, 514428, 544 60, 544129, 544141, 544405, 548579
Abstract:
Disclosed are novel cathepsin S, K, F, L and B reversible inhibitory compounds of the formulas (I), (II), (Ia) and (Ib) further defined herein. The compounds are useful for treating autoimmune diseases. Also disclosed are processes for making such novel compounds.

Heterocyclic Compounds Useful As Inhibitors Of Tyrosine Kinases

View page
US Patent:
6489328, Dec 3, 2002
Filed:
Aug 2, 2001
Appl. No.:
09/921510
Inventors:
Roger John Snow - Danbury CT
Donghong A. Gao - Hopewell Junction NY
Daniel R. Goldberg - Redding CT
Abdelhakim Hammach - Danbury CT
Daniel Kuzmich - Danbury CT
Tina Marie Morwick - New Milford CT
Neil Moss - Ridgefield CT
Robert D. Selliah - Malden MA
Hidenori Takahashi - LaGrangeville NY
Assignee:
Boehringer Ingelheim Pharmaceuticals, Inc. - Ridgefield CT
International Classification:
C07D48704
US Classification:
51425216, 514267, 544250, 544251
Abstract:
Disclosed are novel compounds of formula (I): wherein Ar , X, Y, P, Q and Het are defined herein, which are useful as inhibitors of certain protein tyrosine kinases and are thus useful for treating diseases resulting from inappropriate cell proliferation, which include autoimmune diseases, chronic inflammatory diseases, allergic diseases, transplant rejection and cancer, as well as conditions resulting from cerebral ischemia, such as stroke. Also disclosed are pharmaceutical compositions comprising these compounds, processes for preparing these compounds and novel intermediate compounds useful in these processes.

Heterocyclic Compounds Useful As Inhibitors Of Tyrosine Kinases

View page
US Patent:
6506769, Jan 14, 2003
Filed:
Aug 2, 2001
Appl. No.:
09/921509
Inventors:
Roger John Snow - Danbury CT
Mario Cardozo - Brookfield CT
Daniel Goldberg - Redding CT
Abdelhakim Hammach - Danbury CT
Tina Morwick - New Milford CT
Neil Moss - Ridgefield CT
Usha R. Patel - Brookfield CT
Hidenori Takahashi - LaGrangeville NY
Matt Aaron Tschantz - Newtown CT
Xiao-Jun Wang - Danbury CT
Assignee:
Boehringer Ingelheim Pharmaceuticals, Inc. - Ridgefield CT
International Classification:
A61K 314745
US Classification:
514293, 514290, 514393, 514397, 546 82, 546141, 546148, 5462731
Abstract:
Disclosed are novel compounds of formula (I): wherein Ar , R , R , R , X and Y are defined below, which are useful as inhibitors of certain protein tyrosine kinases and are thus useful for treating diseases associated with such kinases, for example, diseases resulting from inappropriate cell proliferation, which include autoimmune diseases, chronic inflammatory diseases, allergic diseases, transplant rejection and cancer, as well as conditions resulting from cerebral ischemia, such as stroke. Also disclosed are processes for preparing these compounds, novel intermediates useful in these processes and compositions comprising compounds of the formula (I).

Compounds Useful As Reversible Inhibitors Of Cathepsin S

View page
US Patent:
6608057, Aug 19, 2003
Filed:
Oct 24, 2001
Appl. No.:
10/082952
Inventors:
Charles L. Cywin - Bethel CT
Michel J. Emmanuel - Danbury CT
Tina Morwick - New Milford CT
Denice M. Spero - West Redding CT
David S. Thomson - Ridgefield CT
Yancey D. Ward - Sandy Hook CT
Assignee:
Boehringer Ingelheim Pharmaceuticals, Inc. - Ridgefield CT
International Classification:
A61K 31535
US Classification:
5142328, 5142332, 5142335, 5142338, 5142342, 5142345, 5142348, 5142352, 5142355, 5142362, 5142365, 5142368, 544115, 544116, 544118, 544126, 544128, 544135, 544138, 544139, 544140, 544141, 544142, 544143, 544145, 544146, 544147, 544152, 544153
Abstract:
Disclosed are cathepsin S reversible inhibitory compounds of the formulas (I),(Ia) and (II),(IIa) as defined herein. The compounds are useful for treating autoimmune diseases. Also disclosed are processes for making such novel compounds.

Compounds Useful As Reversible Inhibitors Of Cathespin S

View page
US Patent:
6730671, May 4, 2004
Filed:
Feb 13, 2003
Appl. No.:
10/366282
Inventors:
Charles L. Cywin - Bethel CT
Michel J. Emmanuel - Danbury CT
Tina Morwick - New Milford CT
Denice M. Spero - West Redding CT
David S. Thomson - Ridgefield CT
Yancey D. Ward - Sandy Hook CT
Assignee:
Boehringer Ingelheim Pharmaceuticals, Inc. - Ridgefield CT
International Classification:
C07D41702
US Classification:
5142328, 5142335, 5142338, 5142342, 5142345, 5142348, 5142352, 5142355, 5142332, 5142362, 5142365, 5142368, 514317, 514318, 514319, 514333, 514336, 514354, 514355, 544115, 544116, 544118, 544126, 544128, 544135, 544138, 544139, 544140, 544141, 544142, 544143, 544145, 544146, 544147, 544152, 544153, 546192, 546195, 546197, 546245
Abstract:
Disclosed are cathepsin S reversible inhibitory compounds of the formulas (I),(Ia) and (II),(IIa) as defined herein. The compounds are useful for treating autoimmune diseases. Also disclosed are processes, for making such novel compounds.

Heterocyclic Compounds Useful As Inhibitors Of Tyrosine Kinases

View page
US Patent:
6770639, Aug 3, 2004
Filed:
Nov 12, 2002
Appl. No.:
10/292026
Inventors:
Roger John Snow - Danbury CT
Mario Cardozo - Brookfield CT
Daniel Goldberg - Redding CT
Abdelhakim Hammach - Danbury CT
Tina Morwick - New Milford CT
Neil Moss - Ridgefield CT
Usha R. Patel - Brookfield CT
Hidenori Takahashi - LaGrangeville NY
Matt Aaron Tschantz - Newtown CT
Xiao-Jun Wang - Danbury CT
Assignee:
Boehringer Ingelheim Pharmaceuticals, Inc. - Ridgefield CT
International Classification:
A61K 3133
US Classification:
514183, 514293, 514290, 514393, 514397, 546 82, 546141, 546148, 5462731
Abstract:
Disclosed are novel compounds of formula (I): wherein Ar , R , R , R , X and Y are defined below, which are useful as inhibitors of certain protein tyrosine kinases and are thus useful for treating diseases associated with such kinases, for example, diseases resulting from inappropriate cell proliferation, which include autoimmune diseases, chronic inflammatory diseases, allergic diseases, transplant rejection and cancer, as well as conditions resulting from cerebral ischemia, such as stroke. Also disclosed are processes for preparing these compounds, novel intermediates useful in these processes and compositions comprising compounds of the formula (I).

Heterocyclic Compounds Useful As Inhibitors Of Tyrosine Kinases

View page
US Patent:
6844435, Jan 18, 2005
Filed:
Oct 15, 2002
Appl. No.:
10/271222
Inventors:
Roger John Snow - Danbury CT, US
Donghong A. Gao - Hopewell Junction NY, US
Daniel R. Goldberg - Redding CT, US
Abdelhakim Hammach - Danbury CT, US
Daniel Kuzmich - Danbury CT, US
Tina Marie Morwick - New Milford CT, US
Neil Moss - Ridegefield CT, US
Robert D. Selliah - Malden MA, US
Hidenori Takahashi - LaGrangeville NY, US
Assignee:
Boehringer Ingelheim Pharmaceuticals, Inc. - Ridgefield CT
International Classification:
C07D48704
C07D23514
US Classification:
544250, 544251, 5483047, 5483074
Abstract:
Disclosed are novel compounds of formula (I): wherein Ar, X, Y, P, Q and Het are defined herein, which are useful as inhibitors of certain protein tyrosine kinases and are thus useful for treating diseases resulting from inappropriate cell proliferation, which include autoimmune diseases, chronic inflammatory diseases, allergic diseases, transplant rejection and cancer, as well as conditions resulting from cerebral ischemia, such as stroke. Also disclosed are pharmaceutical compositions comprising these compounds, processes for preparing these compounds and novel intermediate compounds useful in these processes.

Substituted 3-Amino-Thieno [2,3-B]Pyridine-2-Carboxylic Acid Amide Compounds And Processes For Preparing And Their Uses

View page
US Patent:
6964956, Nov 15, 2005
Filed:
Jun 3, 2003
Appl. No.:
10/453175
Inventors:
Charles L. Cywin - Bethel CT, US
Zhidong Chen - New Milford CT, US
Roman Wolfgang Fleck - Greenwich CT, US
Ming-Hong Hao - Ridgefield CT, US
Eugene Hickey - Danbury CT, US
Weimin Liu - Sandy Hook CT, US
Daniel Richard Marshall - Norwalk CT, US
Peter Nemoto - Southbury CT, US
Ronald John Sorcek - Bethel CT, US
Sanxing Sun - Danbury CT, US
Jiang-Ping Wu - Danbury CT, US
Tina Morwick - New Milford CT, US
Jonathan Emeigh - Gilbertsville PA, US
Assignee:
Boehringer Ingelheim Pharmaceuticals, Inc. - Ridgefield CT
International Classification:
A61K031/4365
A61K031/551
A61K031/496
C07D495/04
US Classification:
51421115, 51421704, 514218, 5142282, 51425304, 514301, 540492, 540544, 540575, 540597, 544 60, 544362, 546114
Abstract:
Disclosed are compounds of formula (I): wherein Rand Rare defined herein, which are useful as inhibitors of the kinase activity of the IκB kinase (IKK) complex. The compounds are therefore useful in the treatment of IKK mediated diseases including autoimmune diseases inflammatory diseases and cancer. Also disclosed are pharmaceutical compositions comprising these compounds and processes for preparing these compounds.
Control profile
Tina M Morwick from Carmel, IN, age ~74 Get Report